2.4.0.6 Html 278 279 1 false 60 0 false 5 false false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.chelseatherapeutics.com/role/DOCUMENTANDENTITYINFORMATION DOCUMENT AND ENTITY INFORMATION true false R2.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.chelseatherapeutics.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.chelseatherapeutics.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Sheet http://www.chelseatherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY false false R6.htm 006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParenthetical CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Parenthetical] false false R7.htm 007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.chelseatherapeutics.com/role/CondensedConsolidatedStatementOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/ConsolidatedStatementsOfCashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] false false R9.htm 009 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPolicies The Company, Basis of Presentation and Summary of Significant Accounting Policies false false R10.htm 010 - Disclosure - Short-term Investments Sheet http://www.chelseatherapeutics.com/role/ShorttermInvestments Short-term Investments false false R11.htm 011 - Disclosure - Fair Value Measurements Sheet http://www.chelseatherapeutics.com/role/FairValueMeasurements Fair Value Measurements false false R12.htm 012 - Disclosure - Property and equipment Sheet http://www.chelseatherapeutics.com/role/PropertyPlantAndEquipment Property and equipment false false R13.htm 013 - Disclosure - Common Stock Offerings Sheet http://www.chelseatherapeutics.com/role/CommonStockOfferings Common Stock Offerings false false R14.htm 014 - Disclosure - Commitments Sheet http://www.chelseatherapeutics.com/role/Commitments Commitments false false R15.htm 015 - Disclosure - Stockholders' Equity Sheet http://www.chelseatherapeutics.com/role/StockholdersEquity Stockholders' Equity false false R16.htm 016 - Disclosure - Income Taxes Sheet http://www.chelseatherapeutics.com/role/IncomeTaxes Income Taxes false false R17.htm 017 - Disclosure - Legal Proceedings Sheet http://www.chelseatherapeutics.com/role/LegalProceedings Legal Proceedings false false R18.htm 018 - Disclosure - Savings and Retirement Plan Sheet http://www.chelseatherapeutics.com/role/SavingsAndRetirementPlan Savings and Retirement Plan false false R19.htm 019 - Disclosure - Restructuring Sheet http://www.chelseatherapeutics.com/role/Restructuring Restructuring false false R20.htm 020 - Disclosure - Subsequent Events Sheet http://www.chelseatherapeutics.com/role/SubsequentEvents Subsequent Events false false R21.htm 021 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.chelseatherapeutics.com/role/TheCompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies The Company, Basis of Presentation and Summary of Significant Accounting Policies (Policies) false false R22.htm 022 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.chelseatherapeutics.com/role/TheCompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables The Company, Basis of Presentation and Summary of Significant Accounting Policies (Tables) false false R23.htm 023 - Disclosure - Property and equipment (Tables) Sheet http://www.chelseatherapeutics.com/role/PropertyAndEquipmentTables Property and equipment (Tables) false false R24.htm 024 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityTables Stockholders' Equity (Tables) false false R25.htm 025 - Disclosure - Income Taxes (Tables) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesTables Income Taxes (Tables) false false R26.htm 026 - Disclosure - Restructuring (Tables) Sheet http://www.chelseatherapeutics.com/role/RestructuringTables Restructuring (Tables) false false R27.htm 027 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://www.chelseatherapeutics.com/role/TheCompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details) false false R28.htm 028 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 1) Sheet http://www.chelseatherapeutics.com/role/Companybasisofpresentationandsummaryofsignificantaccountingpoliciesdetails1 The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 1) false false R29.htm 029 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 2) Sheet http://www.chelseatherapeutics.com/role/Companybasisofpresentationandsummaryofsignificantaccountingpoliciesdetails2 The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 2) false false R30.htm 030 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.chelseatherapeutics.com/role/Companybasisofpresentationandsummaryofsignificantaccountingpoliciesdetailstextual The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) false false R31.htm 031 - Disclosure - Short-term Investments (Details Textual) Sheet http://www.chelseatherapeutics.com/role/ShortTermInvestmentsDetailsTextual Short-term Investments (Details Textual) false false R32.htm 032 - Disclosure - Fair Value Measurements (Details Textual) Sheet http://www.chelseatherapeutics.com/role/FairValueMeasurementsDetailsTextual Fair Value Measurements (Details Textual) false false R33.htm 033 - Disclosure - Property and equipment (Details) Sheet http://www.chelseatherapeutics.com/role/PropertyAndEquipmentDetails Property and equipment (Details) false false R34.htm 034 - Disclosure - Property and equipment (Details Textual) Sheet http://www.chelseatherapeutics.com/role/PropertyAndEquipmentDetailsTextual Property and equipment (Details Textual) false false R35.htm 035 - Disclosure - Common Stock Offerings (Details Textual) Sheet http://www.chelseatherapeutics.com/role/CommonStockOfferingsDetailsTextual Common Stock Offerings (Details Textual) false false R36.htm 036 - Disclosure - Commitment (Details Textual) Sheet http://www.chelseatherapeutics.com/role/CommitmentDetailsTextual Commitment (Details Textual) false false R37.htm 037 - Disclosure - Stockholders' Equity (Details) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails Stockholders' Equity (Details) false false R38.htm 038 - Disclosure - Stockholders' Equity (Details 1) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails1 Stockholders' Equity (Details 1) false false R39.htm 039 - Disclosure - Stockholder's Equity (Details 2) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails2 Stockholder's Equity (Details 2) false false R40.htm 040 - Disclosure - Stockholders' Equity (Details 3) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails3 Stockholders' Equity (Details 3) false false R41.htm 041 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) false false R42.htm 042 - Disclosure - Income Taxes (Details) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesDetails Income Taxes (Details) false false R43.htm 043 - Disclosure - Income Taxes (Details 1) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) false false R44.htm 044 - Disclosure - Income Taxes (Details Textual) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) false false R45.htm 045 - Disclosure - Savings and Retirement Plan (Details Textual) Sheet http://www.chelseatherapeutics.com/role/SavingsAndRetirementPlanDetailsTextual Savings and Retirement Plan (Details Textual) false false R46.htm 046 - Disclosure - Restructuring (Details) Sheet http://www.chelseatherapeutics.com/role/RestructuringDetails Restructuring (Details) false false R47.htm 047 - Disclosure - Restructuring (Details Textual) Sheet http://www.chelseatherapeutics.com/role/RestructuringDetailsTextual Restructuring (Details Textual) false false R48.htm 048 - Disclosure - Subsequent Events (Details Textual) Sheet http://www.chelseatherapeutics.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) false false All Reports Book All Reports Element chtp_EstimatedForfeitureRate had a mix of decimals attribute values: 2 4. Element chtp_PotentialFutureMilestonePayments had a mix of decimals attribute values: -5 0. Element us-gaap_CommonStockParOrStatedValuePerShare had a mix of decimals attribute values: 2 4. Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 2 4. Element us-gaap_PaymentsOfStockIssuanceCosts had a mix of decimals attribute values: -6 -5. Element us-gaap_ResearchAndDevelopmentExpense had a mix of decimals attribute values: -4 0. Element us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost had a mix of decimals attribute values: -5 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. 'Monetary' elements on report '035 - Disclosure - Common Stock Offerings (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '044 - Disclosure - Income Taxes (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: Removing column 'Dec. 31, 2007' Process Flow-Through: Removing column 'Dec. 31, 2006' Process Flow-Through: Removing column 'Dec. 31, 2005' Process Flow-Through: Removing column 'Dec. 31, 2004' Process Flow-Through: Removing column 'Apr. 02, 2002' Process Flow-Through: 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: Removing column 'Mar. 31, 2010' Process Flow-Through: Removing column 'Mar. 31, 2007' Process Flow-Through: Removing column 'Dec. 31, 2006' Process Flow-Through: Removing column 'Feb. 28, 2006' Process Flow-Through: Removing column 'Dec. 31, 2004' Process Flow-Through: Removing column 'Dec. 31, 2002' Process Flow-Through: 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2006' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2005' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2004' Process Flow-Through: 006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Parenthetical] Process Flow-Through: 007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] chtp-20121231.xml chtp-20121231.xsd chtp-20121231_cal.xml chtp-20121231_def.xml chtp-20121231_lab.xml chtp-20121231_pre.xml true true